Clinical impact of second pathology opinion: A longitudinal study of central genitourinary pathology review before prostate brachytherapy

详细信息    查看全文

• 作者：Carys W. Thomas ; Terry C. Bainbridge ; Thomas A. Thomson ; Colleen E. McGahan ; W. James Morris
• 关键词：Pathology review ; Prostate cancer ; Brachytherapy
• 刊名：Brachytherapy
• 出版年：2007
• 出版时间：April-June 2007
• 年：2007
• 卷：6
• 期：2
• 页码：135-141
• 全文大小：138 K

文摘

Purpose

To evaluate the clinical impact of pathology review before prostate brachytherapy.

Methods and materials

Original and reviewing pathologists' reports were retrospectively collected from 1323 men treated with prostate brachytherapy between July 1998 and October 2005 at one institution. Statistical analysis was performed pre- and post-January 2002. The clinical impact of pathology review was evaluated.

Results

Gleason Score (GS) change (GS_Δ) occurred in 25.2 % (334) of cases; GS increased in 21.6 % , decreased in 2.4 % , and diagnosed malignancy in 1.2 % of cases. Post-2002, concordance in attributed GS improved, with GS_Δ of 31.9–20.6 % , respectively (p < 0.001), and a reduction in the average GS_Δ (p < 0.001). The clinical impact was substantial with management changing in 14.8 % of cases.

Conclusion

Concordance between the original and reviewing pathologists' GS has improved during the study period. Nevertheless, discordance persists in one of five cases. Pathology review remains essential, if treatment decisions hinge on GS.